BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24125069)

  • 1. Histone acetyltransferase Hbo1 destabilizes estrogen receptor α by ubiquitination and modulates proliferation of breast cancers.
    Iizuka M; Susa T; Takahashi Y; Tamamori-Adachi M; Kajitani T; Okinaga H; Fukusato T; Okazaki T
    Cancer Sci; 2013 Dec; 104(12):1647-55. PubMed ID: 24125069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
    Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1.
    Wang WZ; Liu HO; Wu YH; Hong Y; Yang JW; Liu YH; Wu WB; Zhou L; Sun LL; Xu JJ; Yun XJ; Gu JX
    J Exp Clin Cancer Res; 2010 Nov; 29(1):140. PubMed ID: 21040551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer.
    Yu L; Liang Y; Cao X; Wang X; Gao H; Lin SY; Schiff R; Wang XS; Li K
    Oncogene; 2017 May; 36(20):2910-2918. PubMed ID: 27893709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.
    Okada M; Ohtake F; Nishikawa H; Wu W; Saeki Y; Takana K; Ohta T
    Mol Endocrinol; 2015 Nov; 29(11):1646-57. PubMed ID: 26389696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
    Band AM; Laiho M
    Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
    Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
    J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.
    Panno ML; Giordano F; Rizza P; Pellegrino M; Zito D; Giordano C; Mauro L; Catalano S; Aquila S; Sisci D; De Amicis F; Vivacqua A; Fuqua SW; Andò S
    Breast Cancer Res Treat; 2012 Nov; 136(2):443-55. PubMed ID: 23053665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of ClC-3 chloride channel by 17β-estradiol relies on the estrogen receptor α expression in breast cancer.
    Yang H; Ma L; Wang Y; Zuo W; Li B; Yang Y; Chen Y; Chen L; Wang L; Zhu L
    J Cell Physiol; 2018 Feb; 233(2):1071-1081. PubMed ID: 28419445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
    Sharma D; Saxena NK; Davidson NE; Vertino PM
    Cancer Res; 2006 Jun; 66(12):6370-8. PubMed ID: 16778215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone acetyltransferase MOF is involved in suppression of endometrial cancer and maintenance of ERα stability.
    Wu Y; Zeng K; Wang C; Wang S; Sun H; Liu W; Wang X; Niu J; Cong SY; Zhou X; Zhao Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):541-548. PubMed ID: 30598260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
    Yang H; Yu N; Xu J; Ding X; Deng W; Wu G; Li X; Hou Y; Liu Z; Zhao Y; Xue M; Yu S; Wang B; Li X; Niu G; Wang H; Zhu J; Zhuang T
    J Exp Clin Cancer Res; 2018 Feb; 37(1):24. PubMed ID: 29433542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA MIAT is estrogen-responsive and promotes estrogen-induced proliferation in ER-positive breast cancer cells.
    Li Y; Jiang B; Wu X; Huang Q; Chen W; Zhu H; Qu X; Xie L; Ma X; Huang G
    Biochem Biophys Res Commun; 2018 Sep; 503(1):45-50. PubMed ID: 29792859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MOF upregulates the estrogen receptor α signaling pathway by its acetylase activity in hepatocellular carcinoma.
    Wei S; Liu W; Sun N; Wu Y; Song H; Wang C; Wang S; Zou R; Lin L; Zeng K; Zhou B; Wang M; Luan R; Yang F; Zhao Y
    Cancer Sci; 2021 May; 112(5):1865-1877. PubMed ID: 33544437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
    Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
    Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 20. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.